| Literature DB >> 34252495 |
Jinqian Li1, Qing Zhou1, Liang Rong1, Dade Rong2, Yang Yang1, Jiawei Hao1, Zhenzhen Zhang1, Ling Ma1, Guirong Rao3, Yuanping Zhou4, Fei Xiao5, Chengyao Li6, Haihe Wang2, Yi-Ping Li7.
Abstract
Globally, hepatitis C virus (HCV) genotype 1b is the most prevalent, and its infection has been found to associate with a higher risk of hepatocellular carcinoma (HCC) than other genotype viruses. However, an efficient infectious HCV genotype 1b culture system is unavailable, which has largely hampered the study of this important genotype virus. In this study, by using a systematic approach combining the sequences of infectious 1a TNcc clone and adaptive mutations, we succeeded in culture adaption of two full-length 1b clones for the reference strain Con1 and a clinical isolate A6, and designated as Con1cc and A6cc, respectively. Con1cc and A6cc replicated efficiently in hepatoma Huh7.5.1 cells, released HCV infectivity titers of 104.1 and 103.72 focus forming units per milliliter, respectively, and maintained the engineered mutations after passages. Both viruses responded to sofosbuvir and velpatasvir in a dose-dependent manner. With culture infectious 1b clones, we characterized the transcriptomes of 1b Con1cc-infected cells, in comparison with 2a-infected and uninfected cells. In conclusion, we have developed two infectious clones for genotype 1b and shown a novel strategy for culture adaptation of HCV isolates by using a genetically close backbone sequence. Furthermore, this study provides transcriptional landscape of HCV 1b-infected hepatoma cells facilitating the study of genotype 1b infection.Entities:
Keywords: Adaptive mutation; Antiviral drugs; Genotype; Infectious clone; Transcriptome
Mesh:
Substances:
Year: 2021 PMID: 34252495 DOI: 10.1016/j.antiviral.2021.105136
Source DB: PubMed Journal: Antiviral Res ISSN: 0166-3542 Impact factor: 5.970